Search PubMed⌕ Search

Biomedical subjects

W M Daggett

Publications and source records attributed to W M Daggett.

At least 91 records · Page 5Linked to original sources
PubMed1981

Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction.

One hundred five patients underwent mitral valve replacement for relief of isolated mitral regurgitation between 1974 and 1979. There were 4 in-hospital deaths (4 percent) and 12 late deaths giving an 82 percent predicted 5 year survival rate. An age of 60 years or more at the time of surgery and a preoperative left ventricular ejection fraction of less than 0.40 were the only variables that correlated with decreased survival at 3 to 5 years after operation (p less than 0.05). Postoperatively, 87 (98 percent) of 89 long-term survivors were in New York Heart Association functional class I or II (68 in class I and 19 in class II). Survival did not differ between patients with porcine versus mechanical valve replacement, but patients with a mechanical valve had a greater incidence of postoperative cerebrovascular accident (8.6/100 patient years) than did patients with a porcine valve (2.8/100 patient years) (p less than 0.002). Ejection fraction at rest was determined with multigated cardiac imaging 12 to 75 months postoperatively in 34 of 89 long-term survivors. The mean preoperative ejection fraction was 0.62 +/- 0.09 (mean +/- 1 standard deviation) and the mean postoperative ejection fraction was 0.50 +/- 0.15 (p less than 0.001). When the preoperative value was compared with the postoperative value at rest the ejection fraction increased by 0.10 or more in 1 patient (3 percent), remained within +/- 0.09 of the preoperative value in 12 patients (35 percent) and decreased by 0.10 or greater in 21 patients (62 percent). Sixteen (94 percent) of 17 patients whose postoperative ejection fraction was greater than 0.50 were in functional class I postoperatively compared with 11 (65 percent) of 17 patients whose postoperative ejection fraction was 0.50 or less (p less than 0.05). No preoperative factor, including preoperative ejection fraction or cardiothoracic ratio, predicted the postoperative ejection fraction. A postoperative exercise ejection fraction was obtained in 29 patients, and an abnormal ejection fraction change with exercise (increase less than 0.05) was observed in 20 patients (69 percent). Patient age at the time of study correlated inversely with the change in ejection fraction from rest to exercise; no other variables were predictive. It is concluded that, in addition to age, only preoperative left ventricular function as measured by ejection fraction predicts survival in patients undergoing mitral valve replacement for isolated mitral regurgitation. Clinical recovery is good even though the majority of long-term survivors have a postoperative decrease in ejection fraction.

Aged↗
PubMed1981

Relation between ionized calcium concentration and ventricular pump performance in the dog under hemodynamically controlled conditions.

The effect of plasma ionized calcium concentration on left ventricular function was studied in the canine heart on right heart bypass. Stroke volume, mean arterial pressure and heart rate were controlled. Plasma ionized calcium was lowered to 0.58 +/- 0.01 mM by citrate infusion and raised to 1.70 +/- 0.01 mM by calcium chloride infusion in random order in each dog. Left ventricular function at each of these ionized calcium levels was compared with that in an immediately preceding normocalcemic period. At a constant stroke work (16.9 +/- 0.2 g-m), sustained hypercalcemia was associated with a small decrease in left ventricular end-diastolic pressure (1.7 +/- 0.7 cm H2O, p less than 0.05) despite a marked increase in peak left ventricular dP/dt (first derivative of ventricular pressure) averaging 34 percent (p less than 0.001). Coronary blood flow, tension-time index and myocardial oxygen consumption were not significantly altered. Stroke work determined at a left ventricular end-diastolic pressure of 14 cm H2O, by interpolation in left ventricular function curves, was 11 +/- 4.4 percent above that at control normocalcemia (p less than 0.05). At a constant stroke work (16.9 +/- 0.2 g-m), sustained hypocalcemia was associated with a marked depression of left ventricular function as demonstrated by a substantial increase (from 4.9 +/- 0.3 to 12.7 +/- 1.1 cm H2O, p less than 0.0001) in left ventricular end-diastolic pressure (p less than 0.0001), decreased mean systolic ejection rate (p less than 0.01) and decreased peak left ventricular dP/dt (p less than 0.0001). Coronary blood flow increased (p less than 0.05) whereas myocardial oxygen consumption did not change significantly. A marked displacement of left ventricular function curves to the right (compared with curves obtained during normocalcemia) was observed, and stroke work determined at a left ventricular end-diastolic pressure of 14 cm H2O was 52 +/- 5.4 percent below control level (p less than 0.001). It appears that hypercalcemia, when initiated from a normal control level, provides only a small enhancement of ventricular pump performance (as indexed by the stroke work-left ventricular end-diastolic pressure relation) despite a marked increase in peak left ventricular dP/dt, whereas marked improvement of left ventricular performance may be expected when calcium infusion is initiated from an ionized calcium level that is below normal.

Animals↗
PubMed1981

Regional myocardial protection during aortic cross-lamp ischemia in dogs: calcium-containing crystalloid solutions.

To study the effects of calcium in cardioplegic solutions, an in situ dog heart model was used that allowed infusion of two different cardioplegic solutions into separate regions of the same heart. Two concentrations of ionized calcium, 1.0 mM and 0.5 mM, in a cold, potassium-containing solution were tested in two groups of dogs and compared with the same cold, potassium-containing solution but without the calcium, during 100 minutes of global myocardial ischemia induced by aortic clamping. Results were evaluated in terms of percent change of regional systolic shortening measured with ultrasonic piezoelectric crystals, percent change of regional myocardial blood flow, and change of regional left ventricular myocardial diastolic distensibility. No significant differences were found between myocardial regions protected with calcium of either concentration and regions protected with calcium of either concentration and regions protected without calcium. This study could demonstrate no beneficial or adverse effects of including calcium in this type of crystalloid cardioplegic solution applied to an in situ dog heart model.

Animals↗
PubMed1981

Aortocoronary bypass grafting in patients without left main stenosis. Relation of risk factors to early and late survival.

Three-hundred and thirty-five patients without left main stenosis or recent acute myocardial infarction underwent isolated aortocoronary bypass grafting during 1974 and 1975. The hospital mortality was 2 per cent for the four-year predicted survival is 94 per cent. Neither the preoperative presence or absence of a progressive or unstable angina pattern, the extent of coronary artery disease, nor the left ventricular ejection fraction predicted postoperative survival. None of the 25 patients whose ejection fraction was 0.30 or less died in the perioperative period, and no late deaths occurred in this subgroup until after 36 months of follow-up, giving a predicted four-year survival rate of 82 per cent. With only one exception, patients in this subgroup were operated on because of angina, which was unstable in three-quarters of them. We believe that this study shows that patients with a severely reduced ejection fraction should not be refused aortocoronary bypass grafting if symptoms of angina are severe and predominate over symptoms of heart failure.

Coronary Artery Bypass↗
PubMed1981

Right ventricular distension and left ventricular compliance.

The constraint of the right ventricle (RV) on the end-diastolic pressure-volume (PV) relationship of the nonischemic and ischemic left ventricle (LV) was studied. The model used was the isovolumic beating LV, with separately perfused ejecting RV with controlled RV distension. The effect of augmented RV distension on the nonischemic LV PV relationship was examined. A change from mild [right ventricular end-diastolic pressure (RVEDP) = 1.5 mm Hg] to severe (RVEDP = 16 mmHg) RV distension resulted in a significant leftward shift of the LV PV relationship. Ischemia was produced for 90 min by reducing flow in the cannulated left main coronary artery and the effect of two levels of stable RV distension on the PV relationship of the ischemic LV was examined. Mild RV distension and moderate (RVEDP = 6 mmHg) RV distension were used. In both groups, there was a progressive leftward shift in the LV PV relationship that was significant by 60 min of ischemia. No change was seen in nonischemic controls. Ventricular relaxation, as described by the time constant of isovolumic relaxation, T, was impaired throughout ischemia but was not sufficiently prolonged to explain the above changes. Thus, the time course of change in the LV PV relationship during ischemia differs from that previously reported after pacing-induced ischemia in humans. Neither the external constraint of the RV nor incomplete relaxation explains this difference.

Animals↗
PubMed1981

Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival.

Forty-one patients with postinfarction ventricular septal rupture were cared for in our hospital during 1971-1975. Cardiogenic shock developed after septal rupture in 55% of these patients. Shock was unrelated to site of infarction, extent of coronary artery disease, left ventricular ejection fraction, or pulmonary-to-systemic flow ratio, but mean pulmonary artery pressure was lower in shock than in nonshock patients. These observations suggest that shock was produced mainly by right ventricular impairment. Perioperative survival was much higher in patients who did not have shock preoperatively (14 of 17 [82+]) than in those who did (three of 11 [27%]). Magnitude of shunt, left ventricular ejection fraction, extent of coronary artery disease, and performance of aortocoronary bypass grafting were not distinctly correlated with perioperative survival. After a minimum 4-year follow-up, 76% of the perioperative survivors are alive, and none suffer more than New York Heart Association functional class II disability. All 13 unoperated patients (11 in shock) died within 3 months.

Aged↗
PubMed1981

Intraaortic balloon counterpulsation in a community hospital.

Our experience with intraaortic balloon counterpulsation in 41 patients documents the feasibility of a coordinated aggressive therapeutic approach in patients with potentially fatal complications of coronary artery disease. The use of intraaortic balloon pump in a non-cardiac surgical center has allowed hemodynamic support in the critically ill, safety in angiography, appropriate selection of patients for surgery, and safe transportation to a cardiac surgery center when indicated.

Adult↗
PubMed1981

Myocardial temperature mapping. Improved intraoperative myocardial preservation.

An improved approach to intraoperative myocardial preservation technique to ensure uniform myocardial cooling past critically stenosed arteries was developed for patients undergoing aorta-coronary bypass grafting. Proximal anastomoses are done and then, after institution of cardiopulmonary bypass, a separate roller pump head is used to administer a specific controlled volume of cardioplegic solution (1 L) through a 4 degrees C coil to provide controlled pressure in the root of the cross-clamped aorta. Midmyocardial wall temperatures in the anterior, posterolateral, inferior, and septal walls of the left ventricle are measured. Distal anastomoses are then performed sequentially, beginning with the warmest region. After each distal anastomosis, 400 ml of cardioplegic solution are again administered into the aortic root. This approach has been used in 100 consecutive patients from July, 1979, through July 1980 (Group I). and these patients were compared to 97 consecutive patients undergoing aorta-coronary bypass grafting in the previous year (July, 1978, through June, 1979) (Group II) who had myocardial preservation with potassium cardioplegia administered by syringe injection and without regional temperature mapping. There were no perioperative myocardial infarctions in Group I: there were five (5.2%) in Group II (p less than 0.05). A significant reduction in cardiac deaths was also achieved, with two (2.0%) such deaths in Group I and eight (8.2%) in Group II (p less than 0.05). The data suggest that delivery of adequate volumes of cardioplegia solutions by a pressure-regulated system, in combination with myocardial temperature mapping to determine the sequence of bypass grafting, can improve myocardial preservation.

Body Temperature↗
PubMed1981

Hemodynamic evaluation of Hancock and Carpentier-Edwards bioprostheses.

The Hancock (H) and Carpentier-Edwards (CE) porcine xenografts are the most commonly used bioprostheses hemodynamic performance of these valves at each valve size was assessed by intraoperative measurement of transvalvular gradients and cardiac outputs in 122 patients undergoing aortic or mitral valve replacement. At comparable cardiac outputs, peak aortic valve gradients (+/- DS) were: 23-mm valve - H (modified orifice) 10.8 +/- 5.9 mm Hg, CE 7.6 +/- 6.2 mm Hg; 25-mm valve - H 11.9 +/- 5.5 mm Hg, CE 8.3 +/- 5.9 mm Hg; 27/29-mm valve - H 11.0 +/- 6.0 mm Hg, CE 6.6 +/- 5.0 mm Hg. Mitral valve gradients were: 29-mm valve - H 3.7 +/- 1.2 mm Hg, CE 2.8 +/- 1.1 mm Hg; 31-mm valve - H 3.5 +/- 1.0 mm Hg, CE 2.6 +/- 0.7 mm Hg, 33/35-mm valve - H 3.2 +/- 1.9 mm Hg. In both the mitral and aortic positions, Carpentier-Edwards porcine bioprostheses had significantly lower (p less than 0.01 and P less than 0.05, respectively) transvalvular gradients than Hancock porcine xenografts.

Aortic Valve↗
PubMed1980

Aortic valve replacement: a 9-year experience.

Experience with aortic valve replacement over a 9-year period is reviewed. Hospital mortality was 5.0%, with an additional late mortality of 15.0% during a mean follow-up period of 4.3 years. There was a 7.5% mortality among the 93 patients who were operated on using direct coronary perfusion. There were no early deaths among the 48 patients operated on using cold cardioplegic arrest. Paravalvular leaks developed in 20 patients, and 9 had reoperation. There were no early deaths following elective reoperations for prosthetic valve dysfunction, but urgent reoperation was associated with a 40% mortality. Eighty percent of all patients are still alive at a maximum follow-up of 9 years. Eighty-six percent of the survivors who were in New York Heart Association Functional Class III or IV before operation are now in Class I or II. Hypothermic cardioplegic arrest was found to be preferable to coronary perfusion as a method of myocardial protection during aortic valve replacement. Patients with paravalvular leaks who have a history of left ventricular failure prior to aortic valve replacement should be considered candidates for early elective reoperation, owing to the significantly greater mortality associated with urgent reoperation.

Adolescent↗
PubMed1980

Late graft patency and symptom relief after aorta-coronary bypass.

One hundred six consecutive patients underwent elective or emergency coronary artery bypass grafting (CABG) between January, 1974, and November, 1975. There were 90 men of an average age of 54 years and 16 women an average of 64 years. Unstable angina (preinfarction angina, angina decubitus, and crescendo angina) was present in 54 patients of this group and eight were in congestive heart failure. Sixty-two of the 106 had previously had myocardial infarctions and four had evolving infarctions. There were four operative deaths (3.8%) and one early hospital death (less than 30 days' hospitalization). Perioperative infarction occurred in five of the survivors. Of the 197 grafts placed in the 101 survivors, 94% were patent by angiography at 1 to 2 weeks (175 of 187 vein grafts and 10 of 10 left internal mammary grafts). At 1 to 2 years after CABG, 62% of the survivors consented to repeat angiography at which time 94% of the grafts were patent (101 of 108 vein grafts and seven of seven left internal mammary grafts). Clinical follow-up of 81 of the 101 survivors at 1 year found 99% of them to be asymptomatic or improved. Repeat clinical follow-up of all survivors (99 of 101) at 3 to 4 years found 93.9% asymptomatic or improved. Overall survival, including operative deaths, was 92.4% at 4 years.

Adult↗
PubMed1980

Myocardial protection with hypothermia and potassium cardioplegia during operation for ascending aortic aneurysms.

The operative management of aneurysms of the ascending aorta continues to present a technical challenge to the surgeon, and the results obtained provide a useful clinical assessment of the means of myocardial protection. We present a series of 35 consecutive patients who underwent operations for aneurysms of the ascending aorta during which myocardial protection was achieved with hypothermia and potassium cardioplegia. Twenty-three patients underwent aortic valve replacement and resection and grafting of a chronic ascending aortic aneurysm. Aortic valve replacement and aneurysmorrhaphy of a chronic ascending aneurysm were performed in five patients. Four patients underwent resection and grafting of a chronic ascending aortic aneurysm and three patients resection and grafting of acute aortic aneurysms. Aortic cross-clamp times varied from 48 minutes to 2 hours, 32 minutes, with a mean cross-clamp time of 1 hour, 29 minutes. There was one death in the hospital in this series of 35 patients for a mortality rate of 2.8%. Of the 34 survivors, there has been one late death from recurrent sternal wound infection. This clinical series documents the efficacy and safety of hypothermic potassium cardioplegia for protection of the myocardium during extended periods of ischemia attending operative correction of ascending aortic aneurysms.

Adolescent↗
PubMed1980

Regional myocardial protection: use of a new method to compare cold potassium cardioplegia with hypothermic coronary perfusion.

A new canine model was developed to compare two cardiplegic agents using each heart as its own control. Paired piezoelectric crystals were implanted into the left anterior descending and circumflex regions. The percentage of shortening (systolic shortening/end-diastolic segment length X 100) was assessed in each region on right-heart bypass over a range of cardiac outputs. Durng 100 minutes of ischemic arrest the left anterior descending and circumflex regions were perfused separately every 20 minutes with either cold buffered saline or cold KCl cardioplegia solutions. After recovery, the percentage of shortening after ischemic arrest was determined. The percentage of shortening in the region protected by KCl was unchanged (12.5 +/- 5.0 to 13.0 +/- 4.6%) after arrest, but was markedly decreased in the buffered saline region (11.3 +/- 5.9 to 3.2 +/- 4.9%) (p < 0.001, n = 6). This model should facilitate the comparison of two cardioplegic solutions.

Animals↗